Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SMD Rise PCLBKK:SMD100-R 59 Days Sales Outstanding is 119.89 as of Mar. 2026, which is 106% above its 10-year median of 58.33. GuruFocus rates BKK:SMD100-R with a GF Score™ of 59/100 and a GF Value™ of ฿22.39. The stock has 6 warning signs investors should review. Among 118 Medical Distribution companies, SMD Rise PCL ranks worse than 51.69% on this metric.
SMD Rise PCL's average Accounts Receivable for the
three
months ended in Mar. 2026 was ฿226.9 Mil. SMD Rise PCL's Revenue for the
three
months ended in Mar. 2026 was ฿172.7 Mil.
Hence, SMD Rise PCL's Days Sales Outstanding for the
three
months ended in Mar. 2026 was 119.89.
The historical rank and industry rank for SMD Rise PCL's Days Sales Outstanding or its related term are showing as below:
BKK:SMD100-R'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 35.31 Med: 58.33 Max: 98.95
Current: 80.2
During the past 8 years, SMD Rise PCL's highest Days Sales Outstanding was 98.95. The lowest was 35.31. And the median was 58.33.
BKK:SMD100-R's Days Sales Outstanding is ranked worse than 51.69% of 118
companies
in the Medical Distribution industry
Industry Median: 79.025
vs BKK:SMD100-R: 80.20
SMD Rise PCL's Days Sales Outstanding
increased
from Mar. 2025 (115.77) to Mar. 2026 (119.89).
SMD Rise PCL (BKK:SMD100-R) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
SMD Rise PCL Days Sales Outstanding Related Terms
SMD Rise PCL Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for SMD Rise PCL's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:SMD100-R vs MCK, CAH, COR: Days Sales Outstanding Comparison
For the Medical Distribution subindustry, SMD Rise PCL's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SMD Rise PCL Days Sales Outstanding vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, SMD Rise PCL's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where SMD Rise PCL's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Days Sales Outstanding of 119.89 mean?
SMD Rise PCL (BKK:SMD100-R) has a Days Sales Outstanding of 119.89 as of Mar. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on SMD Rise PCL and its competitors. This is 106% above median its historical median of 58.33. Over the past decade, SMD Rise PCL's Days Sales Outstanding has ranged from 35.31 to 98.95. According to the industry distribution chart, SMD Rise PCL ranks #61 out of 118 companies in the Medical Distribution industry, placing it in the top 51.7%.
Is SMD Rise PCL's Days Sales Outstanding too high?
SMD Rise PCL's current Days Sales Outstanding of 119.89 is 106% above median its 10-year median of 58.33. Over the past 10 years, this metric has ranged from a low of 35.31 to a high of 98.95. The Medical Distribution industry median Days Sales Outstanding is 79.03. SMD Rise PCL's value of 119.89 is 51.7% above this industry median. Based on the distribution chart, SMD Rise PCL ranks #61 out of 118 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, SMD Rise PCL has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does SMD Rise PCL's Days Sales Outstanding compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, SMD Rise PCL ranks #61 out of 118 companies for Days Sales Outstanding. This places SMD Rise PCL in the lower half of its industry. The industry median Days Sales Outstanding is 79.03. SMD Rise PCL's value of 119.89 is 51.7% above this benchmark. Historically, SMD Rise PCL's own Days Sales Outstanding has ranged from 35.31 to 98.95 over the past decade. While the company's 10-year median is 58.33 vs. the industry median of 79.03, SMD Rise PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Distribution company?
The median Days Sales Outstanding among Medical Distribution companies is 79.03, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SMD Rise PCL's current Days Sales Outstanding of 119.89 is 51.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on SMD Rise PCL and its competitors. For the Medical Distribution industry, the median Days Sales Outstanding is 79.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SMD Rise PCL's current Days Sales Outstanding is 119.89, which is 106% above median its own 10-year median of 58.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SMD Rise PCL stock overvalued right now?
SMD Rise PCL (BKK:SMD100-R) has a current Days Sales Outstanding of 119.89. The stock's GF Value™ is ฿22.39, compared to a current price of ฿5.85 — trading 73.9% below its estimated fair value. The current Days Sales Outstanding is 119.89, which is 106% above median its 10-year median of 58.33 and 51.7% above the Medical Distribution industry median of 79.03. SMD Rise PCL's overall GF Score™ is 59/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For SMD Rise PCL (BKK:SMD100-R), the current Days Sales Outstanding is 119.89 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SMD Rise PCL (BKK:SMD100-R) Overvalued in 2026?
Based on GuruFocus' analysis, SMD Rise PCL stock appears to be undervalued.
The current stock price of ฿5.85 is trading 73.9% below its estimated GF Value™ of ฿22.39.
Key valuation signals for BKK:SMD100-R:
Days Sales Outstanding: 119.89 (106% above median its 10-year median of 58.33)
GF Value™: ฿22.39 vs. price of ฿5.85 (73.9% below fair value)
Industry Position: 51.7% above the Medical Distribution median (#61 of 118)
No single metric tells the full story. See the BKK:SMD100-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Address222,222/1-2 Moo 1, Rattanathibet Road, West Inn Complex Building, 10th Floor, Bang Rak Yai Subdistrict, Bang Bua Thong District, Nonthaburi Province, Bangkok, THA, 11110
SMD Rise PCL, formerly Saintmed PCL is engaged in the import and distribution of medical devices and equipment, rental services for medical equipment, and providing services related to medical equipment. It operates in Thailand. The Group is engaged in three operating segments: Sale of medical devices and equipment, medical supplies, Services of medical equipment at sleep lab centers and repair services, and Revenue from rental of medical equipment at wellness centers and other services. The Group is managed and operates principally in Thailand.
59GF Score
Get the complete analysis for BKK:SMD100-R
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:SMD100-R has been successfully added to your 
